BIOMAT Database Logo BIOMAT Database Logo

[Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid]. 1973

M Hanefeld, and J Schulze, and T Fritz, and C Kemmer

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
[Long-term treatment of hyperlipoproteinemia with etofibrate].
September 1993, Fortschritte der Medizin,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
Long-term treatment of type III hyperlipoproteinemia with clofibrate.
January 1981, Atherosclerosis,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
January 1980, Artery,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
February 1978, Medizinische Klinik,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
Problems encountered in long-term treatment with anticoagulants.
January 1976, Acta medica Scandinavica,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
[Clinical problems associated with long-term antihypertensive treatment].
May 1992, Nihon rinsho. Japanese journal of clinical medicine,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
[Current problems in long-term treatment with anticoagulants].
March 1962, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia.
November 1995, Metabolism: clinical and experimental,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
[Exocrine pancreatic insufficiency with familial hyperlipoproteinemia. Pancreatitis-hyperlipoproteinemia problems].
May 1971, Schweizerische medizinische Wochenschrift,
M Hanefeld, and J Schulze, and T Fritz, and C Kemmer
[Problems in long-term benzodiazepine treatment].
July 1989, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Copied contents to your clipboard!